Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hatch

Showing results (231-240 of 241) with videos related to

Pageof 25
Sort By:
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|May 25, 2022
One- and Two-Year Analysis of a Five-Year Prospective Multicenter Study Assessing Radiographic and Patient-Reported Outcomes Following Triplanar First Tarsometatarsal Arthrodesis With Early Weightbearing for Symptomatic Hallux ValgusGeorge T Liu, Avneesh Chhabra, Mindi J Dayton, et al.
Journal of Virology|May 10, 2013
Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaquesGraham J Hatch, Victoria A Graham, Kevin R Bewley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
The Oncologist|March 25, 2018
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced CancerGordana Vlahovic, Kellen L Meadows, Ace J Hatch, et al.
Molecular Cancer Therapeutics|August 5, 2020
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving RegorafenibYingmiao Liu, Jing Lyu, Kirsten Bell Burdett, et al.
Scientific Reports|November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Chen Jiang, Alexander B Sibley, et al.
The Oncologist|January 20, 2021
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal CancerJohn H Strickler, Christel N Rushing, Hope E Uronis, et al.
BMC Cancer|November 3, 2019
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancerJohn H Strickler, Christel N Rushing, Donna Niedzwiecki, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2005
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosisAnn Williams, Graham J Hatch, Simon O Clark, et al.
Pageof 25

Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|May 25, 2022
One- and Two-Year Analysis of a Five-Year Prospective Multicenter Study Assessing Radiographic and Patient-Reported Outcomes Following Triplanar First Tarsometatarsal Arthrodesis With Early Weightbearing for Symptomatic Hallux ValgusGeorge T Liu, Avneesh Chhabra, Mindi J Dayton, et al.
Journal of Virology|May 10, 2013
Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaquesGraham J Hatch, Victoria A Graham, Kevin R Bewley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
The Oncologist|March 25, 2018
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced CancerGordana Vlahovic, Kellen L Meadows, Ace J Hatch, et al.
Molecular Cancer Therapeutics|August 5, 2020
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving RegorafenibYingmiao Liu, Jing Lyu, Kirsten Bell Burdett, et al.
Scientific Reports|November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Chen Jiang, Alexander B Sibley, et al.
The Oncologist|January 20, 2021
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal CancerJohn H Strickler, Christel N Rushing, Hope E Uronis, et al.
BMC Cancer|November 3, 2019
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancerJohn H Strickler, Christel N Rushing, Donna Niedzwiecki, et al.
Tuberculosis (Edinburgh, Scotland)|February 3, 2005
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosisAnn Williams, Graham J Hatch, Simon O Clark, et al.
Pageof 25